categories

HOT TOPICS

Building a High-Impact EdTech Venture from Alabama: QuantHub CEO Josh Jones (Part 3)

Posted on Wednesday, Jul 17th 2024

Sramana Mitra: Were you using third party software for these projects? What was the lay of the land in terms of tools and technologies for doing this work at that time?

>>>

Featured Videos

AI Unicorns: Canva Expands to Website Builder Market

Posted on Tuesday, Jul 16th 2024

According to a recent report, the global computer graphics market is projected to grow at 9% CAGR to reach $35.1 billion by 2030. Australia-based Canva is a big player in the industry that has seen strong growth in the past few years.

>>>

Building a High-Impact EdTech Venture from Alabama: QuantHub CEO Josh Jones (Part 2)

Posted on Tuesday, Jul 16th 2024

Sramana Mitra: Okay, so we’re doing an Entrepreneur Journey story. I need a journey. So give me timelines. When did you do what and what led to what and so on. So, you were trying to do this business and your Alabama college education was from what year to what year? Seven years, you said.

Josh Jones: I was at the University of Alabama from 1998 until 2005.

>>>

Video FAQs

Building a High-Impact EdTech Venture from Alabama: QuantHub CEO Josh Jones (Part 1)

Posted on Monday, Jul 15th 2024

Josh is building a Data Science training company from Alabama. It’s a very interesting model, going deep into high school level skill development in what the market needs today.

Sramana Mitra: Hi, Josh. It’s great to have you. Let’s start at the very beginning of your journey. Where are you from? Where were you born, raised? What kind of background?

>>>

1Mby1M Virtual Accelerator Investor Forum: With Julien Pham, 3CC Third Culture Capital (Part 7)

Posted on Sunday, Jul 14th 2024

Sramana Mitra: You must have seen in the media how we’ve advocated very, very seriously bootstrapped startups. As a forum, we have legitimized bootstrapped startups. So today bootstrap startups take a lot of pride. Ten years ago, the bootstrapped startups used to apologize for being bootstrapped startups. Today, they don’t.

>>>

Colors: Tranquility IX

Posted on Sunday, Jul 14th 2024

I’m publishing this series on LinkedIn called Colors to explore a topic that I care deeply about: the Renaissance Mind. I am just as passionate about entrepreneurship, technology, and business, as I am about art and culture. In this series, I will typically publish a piece of art – one of my paintings – and I request you to spend a minute or two deeply meditating on it. I urge you to watch your feelings, thoughts, reactions to the piece, and write what comes to you, what thoughts it triggers, in the dialog area. Let us see what stimulation this interaction yields. For today – Tranquility IX

Tranquility IX | Sramana Mitra, 2022 | Watercolor, Pastel, Ink | 8 x 8, On Paper

Colors: Tranquility VIII

Posted on Saturday, Jul 13th 2024

I’m publishing this series on LinkedIn called Colors to explore a topic that I care deeply about: the Renaissance Mind. I am just as passionate about entrepreneurship, technology, and business, as I am about art and culture. In this series, I will typically publish a piece of art – one of my paintings – and I request you to spend a minute or two deeply meditating on it. I urge you to watch your feelings, thoughts, reactions to the piece, and write what comes to you, what thoughts it triggers, in the dialog area. Let us see what stimulation this interaction yields. For today – Tranquility VIII

Tranquility VIII | Sramana Mitra, 2022 | Watercolor, Pastel, Ink | 8 x 8, On Paper

1Mby1M Virtual Accelerator Investor Forum: With Julien Pham, 3CC Third Culture Capital (Part 6)

Posted on Saturday, Jul 13th 2024

Sramana Mitra: I’m asking a simpler question. Are these all B to B companies – businesses selling to hospitals or insurance companies or pharmaceutical companies?

Julien Pham: Oh, we do a little bit of everything. We have a few B to C, B to B, or B to B to C companies because end user oftentimes is the patient. If you remember, one of our important screening criteria of the quintuple aim is, how does it improve outcomes for patients? So we want to make sure that it somehow touches patients.

>>>